This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1995 Jan 26;332(4):271-2; author reply 272-3.

Deferoxamine in thalassemia major

M Cazzola, F Locatelli, P De Stefano

PMID: 7808503

Comment

Deferoxamine in thalassemia major

M Cazzola et al. N Engl J Med. 1995.

. 1995 Jan 26;332(4):271-2; author reply 272-3.

Authors

M Cazzola, F Locatelli, P De Stefano

PMID: 7808503

No abstract available

PubMed Disclaimer

Comment on

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.
Brittenham GM, Griffith PM, Nienhuis AW, McLaren CE, Young NS, Tucker EE, Allen CJ, Farrell DE, Harris JW. Brittenham GM, et al. N Engl J Med. 1994 Sep 1;331(9):567-73. doi: 10.1056/NEJM199409013310902. N Engl J Med. 1994. PMID: 8047080
Survival in medically treated patients with homozygous beta-thalassemia.
Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Olivieri NF, et al. N Engl J Med. 1994 Sep 1;331(9):574-8. doi: 10.1056/NEJM199409013310903. N Engl J Med. 1994. PMID: 8047081

Similar articles

Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases.
Vaskaridou E, Konstantopoulos K, Kyriakou D, Loukopoulos D. Vaskaridou E, et al. Haematologica. 1993 May-Jun;78(3):183-4. Haematologica. 1993. PMID: 8375749
Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.
Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Dürken M, Nielsen P. Grosse R, et al. Ann N Y Acad Sci. 2005;1054:429-32. doi: 10.1196/annals.1345.074. Ann N Y Acad Sci. 2005. PMID: 16339692
Deferoxamine in thalassemia major.
Lucarelli G, Clift R, Angelucci E. Lucarelli G, et al. N Engl J Med. 1995 Jan 26;332(4):271; author reply 272-3. N Engl J Med. 1995. PMID: 7808502 No abstract available.
Current trends in management of the beta thalassemias.
Shah D, Choudhury P, Dubey AP. Shah D, et al. Indian Pediatr. 1999 Dec;36(12):1229-42. Indian Pediatr. 1999. PMID: 10745364 Review. No abstract available.
[Therapeuetic management of patients with thalassemia major].
Thuret I. Thuret I. Bull Soc Pathol Exot. 2001 May;94(2):95-7. Bull Soc Pathol Exot. 2001. PMID: 11475036 Review. French.

See all similar articles

Cited by

Adipose-Derived Stromal Cell-Based Therapies for Radiation-Induced Fibrosis.
Berry CE, Abbas DB, Lintel HA, Churukian AA, Griffin M, Guo JL, Cotterell AC, Parker JBL, Downer MA, Longaker MT, Wan DC. Berry CE, et al. Adv Wound Care (New Rochelle). 2024 May;13(5):235-252. doi: 10.1089/wound.2022.0103. Epub 2022 Dec 9. Adv Wound Care (New Rochelle). 2024. PMID: 36345216 Free PMC article. Review.
Deferoxamine to Minimize Fibrosis During Radiation Therapy.
Tevlin R, Longaker MT, Wan DC. Tevlin R, et al. Adv Wound Care (New Rochelle). 2022 Oct;11(10):548-559. doi: 10.1089/wound.2021.0021. Epub 2021 Jul 26. Adv Wound Care (New Rochelle). 2022. PMID: 34074152 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.